Generic placeholder image

Current Drug Safety


ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Case Report

A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome

Author(s): Vaibhav Rajendra Suryawanshi, Bharat Purandare, Sujata Rege and Bijoy Kumar Panda*

Volume 18, Issue 3, 2023

Published on: 20 August, 2022

Page: [393 - 397] Pages: 5

DOI: 10.2174/1574886317666220707144418

Price: $65


Purpose: The simultaneous occurrence of cerebral toxoplasmosis and cryptococcosis is rare. The infections continue to be treated with sulfadiazine and amphotericin-B-based regimens (preferred therapy), respectively. Both these drugs are linked to some serious adverse drug reactions (ADRs). We report such a unique instance of both; the CNS co-infections and adverse drug reactions to the preferred therapy.

Case Presentation: A 44-year-old Asian-Indian female was diagnosed with cerebral toxoplasmosis, impending cryptococcal meningoencephalitis, and acquired immune deficiency syndrome (AIDS). The preferred therapy of opportunistic CNS co-infections commenced. Within a week, she had an occurrence of fall in hemoglobin concentrations (11.3 g/dL to 5.6 g/dL; grade IV), reticulocytosis (1% to 3.2%), and indirect hyperbilirubinemia (0.5 mg/dL to 2.8 mg/dL; grade IV) after sulfadiazine administration. The drug was discontinued and the patient was treated with hematocrit transfusions. After amphotericin-B deoxycholate (AmBd) administration, the patient developed hypokalemia (serum potassium; 4.5 mmol/L to 2.7 mmol/L) and increased serum creatinine (1.0 to 2.2 mg/dL; stage-I) levels. Hence, AmBd was discontinued and potassium correction was given. The patient got diagnosed with sulfadiazine induced hemolytic anemia and AmBd induced acute renal failure. He was switched to alternative therapy regimens for the treatment of cerebral toxoplasmosis and cryptococcosis. Radiological investigations were followed up to confirm the clinical outcomes of alternative therapy. Complete recovery from the ADRs and opportunistic infections was observed.

Conclusion: The preferred therapy regimens for toxoplasmosis and cryptococcosis are accompanied by potential adverse drug reactions, thus continuous monitoring is vital, especially in the initial phases of therapy. Discontinuation of the treatment should be the preliminary intervention in the management. Having said that, alternative therapy regimens had an optimal clinical response in the present case.

Keywords: CNS co-infection, adverse reactions, sulfadiazine, amphotericin-B-deoxycholate, HIV/AIDS, CSF.

Koshy JM, Deodhar D, Brar I, et al. Central nervous system manifestations in human immunodeficiency virus patients in the antiretroviral therapy era-Scenario from a developing country. CHRISMED J Health Res 2015; 2(3): 245-50.
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2018. Available from:
Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: A review. J Chemother 2000; 12(6): 463-70.
[] [PMID: 11154026]
Bicanic T, Bottomley C, Loyse A, et al. Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis. Antimicrob Agents Chemother 2015; 59(12): 7224-31.
[] [PMID: 26349818]
Bahls F, Sumi SM. Cryptococcal meningitis and cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome. J Neurol Neurosurg Psychiatry 1986; 49(3): 328-30.
[] [PMID: 3958746]
Murray-Pulsifer K. Two central nervous system infectious diseases in a patient with AIDS. J Fam Pract 1993; 36(6): 660-4.
[PMID: 8505610]
Murty OP. Cerebral toxoplasmosis and cryptococcus meningitis with genital candidiasis: Proven only after autopsy. Mal J For Path Sci 2007; 2: 107-17.
Gonzales Zamora JA. Dual infection of the central nervous system caused by cryptococcus and toxoplasma in a patient with AIDS: A case report and literature review. Acta Clin Belg 2018; 73(6): 448-52.
[] [PMID: 29583086]
Youngster I, Arcavi L, Schechmaster R, et al. Medications and glucose-6-phosphate dehydrogenase deficiency: An evidence-based review. Drug Saf 2010; 33(9): 713-26.
[] [PMID: 20701405]
Pierce A, Nester T. Pathology consultation on drug-induced hemolytic anemia Am J Clin Pathol 2011; 136(1): 7e12.
Botero Aguirre JP, Restrepo Hamid AM. Amphotericin B deoxycholate versus liposomal amphotericin B: Effects on kidney function. Cochrane Database Syst Rev 2015; (11): CD010481
[] [PMID: 26595825]
Rajeshwari SS, Adhikari P, Ramapuram JT, et al. Amphotericin B for cryptococcal meningitis in HIV positive patients: Low dose versus high dose. Indian J Crit Care Med 2007; 11: 112-6.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45.
[] [PMID: 7249508]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy